Pharmacist-Led Medication Counseling
Cross-source consensus on Pharmacist-Led Medication Counseling from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Benefits
Preparation
Risks & contraindications
Background
Highlighted claims
- Both study groups receive standard medication counseling via a standardized prerecorded 10-minute video. — Effect of enhanced support for coping with side effects during medication counselling on the nocebo effect in patients with advanced lung cancer receiving initial chemotherapy: protocol for a multicentre exploratory open-label randomised controlled trial
- The prerecorded video is used to reduce variability across study sites and pharmacists. — Effect of enhanced support for coping with side effects during medication counselling on the nocebo effect in patients with advanced lung cancer receiving initial chemotherapy: protocol for a multicentre exploratory open-label randomised controlled trial
- The video approach reduces bias from pharmacist characteristics including sex, gestures, facial expressions and tone of voice. — Effect of enhanced support for coping with side effects during medication counselling on the nocebo effect in patients with advanced lung cancer receiving initial chemotherapy: protocol for a multicentre exploratory open-label randomised controlled trial
- This study is described as the first to evaluate whether pharmacist-led enhanced coping support can reduce the nocebo effect. — Effect of enhanced support for coping with side effects during medication counselling on the nocebo effect in patients with advanced lung cancer receiving initial chemotherapy: protocol for a multicentre exploratory open-label randomised controlled trial
- Prerecorded video counseling prevents real-time monitoring of patient complexion and mental state, differing from usual clinical practice. — Effect of enhanced support for coping with side effects during medication counselling on the nocebo effect in patients with advanced lung cancer receiving initial chemotherapy: protocol for a multicentre exploratory open-label randomised controlled trial